Researchers at the University of Miami Miller School of Medicine have shown that treat of heart attack patients with adult stem cells can result in repair of heart tissue damage and fewer complications:
The trial, lead by Joshua M. Hare, M.D., director of the Interdisciplinary Stem Cell Institute at the University of Miami Miller School of Medicine, found that the stem cell-treated patients had lower rates of side effects, such as cardiac arrhythmias. Moreover, "they had significant improvements in heart, lung and global function," Hare explained. "Echocardiography showed improved heart function, particularly in those patients with large amounts of cardiac damage."
See link for more.
The trial of 53 patients at 10 U.S. centers since 2005 was sponsored by Osiris Therapeutics and involved the use of mesenchymal stem cells.